Table 2.
Indicators of the intervention group and the control group (mean ± SD)
|
Indicators
|
IG, n = 80
|
CG, n = 78
|
||||||
|
Baseline
|
1st mo
|
3rd mo
|
6th mo
|
Baseline
|
1st mo
|
3rd mo
|
6th mo
|
|
| Inflammation level | ||||||||
| CRP (mg/L) | 17.74 ± 5.65 | 15.05 ± 4.51 | 10.83 ± 3.84 | 2.40 ± 2.00 | 18.25 ± 5.41 | 16.71 ± 4.42 | 15.13 ± 3.35 | 7.93 ± 2.77 |
| ESR (mm/h) | 35.61 ± 5.29 | 31.57 ± 4.81 | 28.03 ± 3.42 | 23.97 ± 3.14 | 35.36 ± 5.41 | 32.85 ± 4.58 | 29.81 ± 3.36 | 28.21 ± 2.82 |
| TNF-α (pg/mL) | 43.93 ± 9.04 | 38.22 ± 8.05 | 33.24 ± 7.98 | 29.61 ± 6.72 | 42.99 ± 10.15 | 41.01 ± 9.72 | 38.12 ± 9.14 | 35.56 ± 8.12 |
| Disease activity | ||||||||
| CDAI | 19.97 ± 7.29 | 20.00 ± 7.25 | 13.90 ± 5.17 | 4.51 ± 1.94 | 20.04 ± 8.01 | 19.51 ± 7.95 | 17.94 ± 6.93 | 15.41 ± 5.26 |
| SDAI | 37.71 ± 8.67 | 35.06 ± 8.11 | 24.73 ± 5.99 | 6.91 ± 2.49 | 38.29 ± 8.78 | 36.22 ± 8.22 | 33.06 ± 7.03 | 23.34 ± 5.24 |
| DAS28 | 4.94 ± 1.29 | 4.56 ± 1.00 | 4.02 ± 0.78 | 3.40 ± 1.00 | 4.89 ± 1.33 | 4.94 ± 1.29 | 4.50 ± 1.25 | 4.13 ± 0.93 |
| HAQ | 1.39 ± 0.64 | 1.04 ± 0.59 | 1.12 ± 0.65 | 0.36 ± 0.28 | 1.43 ± 0.70 | 1.24 ± 0.72 | 1.22 ± 0.66 | 0.91 ± 0.58 |
| Mood disorder | ||||||||
| SDS | 57.31 ± 4.77 | 46.60 ± 5.67 | 37.63 ± 5.14 | 31.81 ± 9.82 | 58.45 ± 6.15 | 50.95 ± 6.09 | 51.62 ± 5.77 | 49.58 ± 6.13 |
| SAS | 54.43 ± 8.34 | 49.81 ± 7.52 | 40.60 ± 6.32 | 31.71 ± 8.84 | 53.21 ± 10.91 | 53.01 ± 10.84 | 49.22 ± 7.34 | 45.13 ± 9.39 |
IG: Intervention group; CG: Control group; CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; TNF-α: Tumor necrosis factor; SDAI: Simplified disease activity index; DAS28: Disease activity score with 28-joint count; CDAI: Clinical disease activity index; HAQ: Health assessment questionnaire; SDS: Self-rating depression scale; SAS: Self-rating anxiety scale.